Nature Communications (Feb 2021)
Structural basis for ligand recognition of the neuropeptide Y Y2 receptor
Abstract
The human neuropeptide Y receptor Y2 (Y2R) is a drug target for the treatment of obesity and anxiety. Crystal structure of Y2R bound to a selective antagonist and accompanying mutagenesis provide insights into ligand recognition and subtype specificity of NPY receptors.